α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease.
α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson's disease.
复制标题
DOI:
10.1038/s41467-018-04422-2
复制
发表时间:
2018-06-12
影响因子:
16.6
通讯作者:
Gandhi S
中科院分区:
文献类型:
--
作者:
Ludtmann MHR;Angelova PR;Horrocks MH;Choi ML;Rodrigues M;Baev AY;Berezhnov AV;Yao Z;Little D;Banushi B;Al-Menhali AS;Ranasinghe RT;Whiten DR;Yapom R;Dolt KS;Devine MJ;Gissen P;Kunath T;Jaganjac M;Pavlov EV;Klenerman D;Abramov AY;Gandhi S
Protein aggregation causes α-synuclein to switch from its physiological role to a pathological toxic gain of function. Under physiological conditions, monomeric α-synuclein improves ATP synthase efficiency. Here, we report that aggregation of monomers generates beta sheet-rich oligomers that localise to the mitochondria in close proximity to several mitochondrial proteins including ATP synthase. Oligomeric α-synuclein impairs complex I-dependent respiration. Oligomers induce selective oxidation of the ATP synthase beta subunit and mitochondrial lipid peroxidation. These oxidation events increase the probability of permeability transition pore (PTP) opening, triggering mitochondrial swelling, and ultimately cell death. Notably, inhibition of oligomer-induced oxidation prevents the pathological induction of PTP. Inducible pluripotent stem cells (iPSC)-derived neurons bearing SNCA triplication, generate α-synuclein aggregates that interact with the ATP synthase and induce PTP opening, leading to neuronal death. This study shows how the transition of α-synuclein from its monomeric to oligomeric structure alters its functional consequences in Parkinson’s disease. How toxic aggregated forms of α-synuclein lead to neurodegeneration is unclear. Here authors use biophysical and cellular imaging methods to show that specific oligomers of α-synuclein exert effects on mitochondria to induce opening of the permeability transition pore, leading to cell death in Parkinson’s disease.
登录
查看更多内容
影响因子:
4
作者:
De Marchi E;Bonora M;Giorgi C;Pinton P
通讯作者:
Pinton P
影响因子:
4
作者:
Angelova PR;Ludtmann MH;Horrocks MH;Negoda A;Cremades N;Klenerman D;Dobson CM;Wood NW;Pavlov EV;Gandhi S;Abramov AY
通讯作者:
Abramov AY
影响因子:
3.7
作者:
Flierl A;Oliveira LM;Falomir-Lockhart LJ;Mak SK;Hesley J;Soldner F;Arndt-Jovin DJ;Jaenisch R;Langston JW;Jovin TM;Schüle B
通讯作者:
Schüle B
影响因子:
168.9
作者:
Chartier-Harlin, MC;Kachergus, J;Destée, A
通讯作者:
Destée, A
影响因子:
3.9
作者:
Allsop, David;Mayes, Jennifer;Tabner, Brian J.
通讯作者:
Tabner, Brian J.